Gensco Pharma, a leading manufacturer of transdermal medications, demonstrates in a randomized controlled trial that SpeedGel Rx® possesses superior results compared to a placebo in the treatment of bruises with no adverse systemic effects.
Trauma sufficient to cause bruising can occur from a wide variety of situations including accidents, falls, and surgeries. To the extent that bruises can occur on the face or exposed areas, and take days or weeks to resolve, they can be a problematic form of temporary disfigurement. Oral analgesics are commonly prescribed to treat bruising, but these agents often produce adverse systemic effects, which can be severe. Additionally, agents with the coagulative properties required to mitigate bruising may potentially induce undesirable systemic coagulative effects.
